Healthcare & Assistive
From da Vinci surgical systems to rehab exoskeletons and elder-care companions, robotics is reshaping healthcare. This section grades what works in the clinic vs the marketing.
Topics in Healthcare & Assistive
24 articles
An objective assessment of the current hardware landscape in soft-tissue surgical robotics, focusing on FDA-cleared systems, pilot deployments, and their specific availability and landed cost estimates within the Indian healthcare market.
An analysis of shipping hardware from ReWalk, Ekso, and Cyberdyne HAL, evaluating clinical evidence for neurological recovery and assessing availability and landed costs within the Indian healthcare market.
An evidence-based analysis of shipping elder-care robotics, focusing on ElliQ, Paro, and Lovot. This article evaluates clinical claims, hardware availability, and the specific challenges of importing assistive technology into the Indian market, distinguishing between therapeutic devices and consumer electronics.
An evidence-based review of autonomous mobile robots in healthcare environments, focusing on Aethon TUG and Moxi deployment data, operational safety, and market entry into India. This article grades claims by shipping hardware status, pilot deployments, and manufacturer specifications rather than concept videos.
An analysis of current shipping surgical robot systems including da Vinci, Hugo, and Versius, focusing on soft-tissue applications, regulatory status, and India market availability.
An evidence-based analysis of shipping rehabilitation exoskeletons including ReWalk, Ekso, and Cyberdyne HAL, focusing on clinical efficacy, regulatory pathways, and Indian market accessibility.
A grounded analysis of ElliQ, Paro, and Lovot. We evaluate shipping status, real-world deployment, pricing, and availability for the Indian market, separating therapeutic claims from commercial reality.
An evidence-based analysis of Automated Mobile Robots in hospitals, focusing on shipping hardware like Aethon TUG and Soft Robotics Moxi. This article evaluates operational utility, India market availability, and realistic cost structures for healthcare facilities.
An analysis of shipping commercial exoskeletons for rehabilitation, separating hardware deployments from concept pitches, with focus on ReWalk, Ekso Bionics, and Cyberdyne HAL.
An evidence-based assessment of ElliQ, Paro, and Lovot in the elder-care sector. This report prioritizes shipped units and pilot deployments over announcements, analyzing India availability, landed costs, and the distinction between therapeutic companionship and physical assistance.
An evidence-based review of hospital Automated Mobile Robots, evaluating Aethon TUG and Fetch Robotics' Moxi against deployment data, safety standards, and Indian market entry barriers.
An analysis of shipping surgical robotics systems, focusing on soft-tissue manipulation technologies like da Vinci, Hugo, and Versius, with specific attention to Indian availability, pricing, and clinical deployment realities.
An analysis of the current state of robotic surgical systems, focusing on soft-tissue procedures, with specific attention to shipping hardware, pilot deployments, and the Indian healthcare context.
A grounded assessment of ReWalk, Ekso, and Cyberdyne HAL, focusing on FDA-cleared shipping hardware, clinical outcomes for neurological conditions, and the financial reality for Indian healthcare providers.
An evidence-based assessment of shipping elder-care hardware including ElliQ, Paro, and Lovot. Analysis covers technical capabilities, deployment pilots, and the stark realities of import costs and service infrastructure in India.
An analysis of Aethon TUG and Diligent Robotics Moxi deployments, focusing on real shipping hardware, India availability, and cost structures for hospital logistics.
An evidence-based assessment of ReWalk, Ekso, and Cyberdyne HAL exoskeletons. This article evaluates shipping hardware, clinical trial data, and India-specific availability, filtering out marketing claims from verifiable medical deployment metrics.
An evidence-based analysis of ElliQ, Paro, and Lovot. This report grades claims by shipping hardware availability, evaluates pilot deployments in nursing facilities, and assesses the feasibility of importing these systems to India amidst regulatory and pricing hurdles.
An evidence-based analysis of Automated Mobile Robots in healthcare settings. This article reviews shipping hardware from Aethon and Fetch Robotics, evaluating real-world deployment in logistics versus nursing assistance, with specific context on India's hospital infrastructure and pricing models.
An evidence-based analysis of the surgical robotics landscape, grading claims by shipping hardware. This article examines the da Vinci Xi/5, Medtronic Hugo, and CMR Versius systems, focusing on soft-tissue applications, Indian market availability, landed costs, and the regulatory reality behind the hype.
A grounded analysis of the da Vinci, Hugo, and Versius systems in the soft-tissue domain, focusing on shipping hardware, deployment metrics, and Indian market entry barriers.
An evidence-based review of the current state of medical rehabilitation exoskeletons. This article evaluates shipping hardware from ReWalk, Ekso Bionics, and Cyberdyne HAL against clinical evidence, regulatory status, and Indian market viability.
An analysis of shipping elder-care robots like Paro, ElliQ, and Lovot, focusing on hardware viability, pricing, and India availability. We grade claims by shipping hardware first, pilot deployments second, and announcements last.
An evidence-based assessment of Aethon TUG and Fetch Robotics Moxi in hospital logistics. This article evaluates shipping hardware, pilot deployments, and realistic ROI for Indian healthcare facilities, distinguishing between supply chain automation and nursing support robots.